Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1ALN-CC5----4件: 11, 62, 66, 109 💬
2ANTI-CCP- and ANTI-P.G.-antibodies titers----1件: 46 💬
3Candesartan plus NON-CCB agents1件: Candesartan1件: Candesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 67 💬
4CC-100004----1件: 84 💬
5CC-10004----5件: 46, 56, 97, 162, 271 💬
6CC-220----1件: 49 💬
7CC-220 0.3 MG daily----1件: 84 💬
8CC-220 0.6MG daily----1件: 84 💬
9CC-292----1件: 46 💬
10CC-4047----2件: 28, 51 💬
11CC-5013----2件: 28, 96 💬
12CC-900011件: CC-90001 (CC-90001)---1件: 85 💬
13CC-930----1件: 85 💬
14CC-93538----1件: 98 💬
15CC-97540----4件: 11, 13, 49, 51 💬
16CC-99677----1件: 271 💬
17CC-99677 30MG capsule----1件: 271 💬
18CC-99677 60MG capsule----1件: 271 💬
19CC100----1件: 2 💬
20CC312----5件: 46, 49, 51, 61, 63 💬
21CCD 1042, MD 9150000, mepalon 1042, SPT316----2件: 152, 206 💬
22CCD 1042, MD 9150000, mepalon 1042, SPT3162----1件: 152 💬
23CCI-779----2件: 13, 46 💬
24CCP-020----1件: 36 💬
25CCR1 antagonist----1件: 46 💬
26CCX 354-C----1件: 46 💬
27CCX-354-C1件: CCX-354 (CCX-354)---1件: 46 💬
28CCX140-B----1件: 222 💬
29CCX168----6件: 43, 44, 49, 66, 109, 222 💬
30CCX282-B----1件: 96 💬
31CCX354-C----1件: 46 💬
32Cyclin D1 gene (CCDN1) /immunoglobulin heavy chain (IGH) fluorescence IN situ hybridization (fish) assay----1件: 28 💬
33OPL-CCL2-LPM----1件: 66 💬
34Pomalidomide (CC-40471件: Pomalidomide1件: Pomalidomide 💬 2件: IL6,
TNF 💬 		78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬